Endothelial dysfunction in patients with recent myocardial infarction and hyperhomocysteinaemia: Effects of vitamin supplementaion

Clinical Science

Volumn 108, Issue 1, 2005, Pages 65-72

  Chia, Stanley ^a   Wilson, Robert ^b   Ludlam, Christopher A ^c   Webb, David J ^b   Flapan, Andrew D ^b   Newby, David E ^b  

^a DEPARTMENT OF CARDIOLOGY   (Singapore)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Endothelial dysfunction; Fibrinolysis; Homocysteine; Myocardial infarction; Vasodilatation; Vitamin

Indexed keywords

ACETYLCHOLINE; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; NITROPRUSSIDE SODIUM; PLASMINOGEN ACTIVATOR INHIBITOR 1; PYRIDOXINE; SUBSTANCE P; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; ENDOTHELIUM INJURY; ENZYME RELEASE; FEMALE; FIBRINOLYSIS; FOLIC ACID BLOOD LEVEL; FOREARM BLOOD FLOW; HUMAN; HYPERHOMOCYSTEINEMIA; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VASODILATATION; VEIN OCCLUSION PLETHYSMOGRAPHY; VITAMIN SUPPLEMENTATION;

ACETYLCHOLINE; ANALYSIS OF VARIANCE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ENDOTHELIUM, VASCULAR; FEMALE; FIBRINOLYSIS; FOREARM; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NITROPRUSSIDE; REGIONAL BLOOD FLOW; SUBSTANCE P; TREATMENT FAILURE; VASODILATOR AGENTS; VITAMINS;

EID: 11144242551     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20040150     Document Type: Article

References (42)

1. Clarke, R., Daly, L., Robinson, K. et al. (1991) Hyperhomocysteinemia: an independent risk factor for vascular disease. N. Engl. J. Med. 324, 1149-1155
2. Stampfer, M. J., Malinow, M. R., Willett, W. C. et al. (1992) A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA, J. Am. Med. Assoc. 268, 877-881
3. Welch, G. N. and Loscalzo, J. (1998) Homocysteine and atherothrombosis. N. Engl. J. Med. 338, 1042-1050
4. Boers, G. H., Smals, A. G., Trijbels, F. J. et al. (1985) Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N. Engl. J. Med. 313, 709-715
5. Nygard, O., Nordrehaug, J. E., Refsum, H., Ueland, P. M., Farstad, M. and Vollset, S. E. (1997) Plasma homocysteine levels and mortality in patients with coronary artery disease. N. Engl. J. Med. 337, 230-236
6. Heitzer, T., Schlinzig, T., Krohn, K., Meinertz, T. and Munzel, T. (2001) Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 104, 2673-2678
7. Halcox, J. P., Schenke, W. H., Zalos, G. et al. (2002) Prognostic value of coronary vascular endothelial dysfunction. Circulation 106, 653-658
8. Stamler, J. S., Osborne, J. A., Jaraki, O. et al. (1993) Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J. Clin. Invest. 91, 308-318
9. Lentz, S. R., Sobey, C. G., Piegors, D. J. et al. (1996) Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia. J. Clin. Invest. 98, 24-29
10. Kanani, P. M., Sinkey, C. A., Browning, R. L., Allaman, M., Knapp, H. R. and Haynes, W. G. (1999) Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans. Circulation 100, 1161-1168
11. Celermajer, D. S., Sorensen, K., Ryalls, M. et al. (1993) Impaired endothelial function occurs in the systemic arteries of children with homozygous homocystinuria but not in their heterozygous parents. J. Am. Coll. Cardiol. 22, 854-858
12. Tawakol, A., Omland, T., Gerhard, M., Wu, J. T. and Creager, M. A. (1997) Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation 95, 1119-1121
13. Labinjoh, C., Newby, D. E., Wilkinson, I. B. et al. (2001) Effects of acute methionine loading and vitamin C on endogenous fibrinolysis, endothelium-dependent vasomotion and platelet aggregation. Clin. Sci. 100, 127-135
14. Freyburger, G., Labrouche, S., Sassoust, G., Rouanet, F., Javorschi, S. and Parrot, F. (1997) Mild hyperhomocysteinemia and hemostatic factors in patients with arterial vascular diseases. Thromb. Haemostasis 77, 466-471
15. Kuller, L. H. and Evans, R. W. (1998) Homocysteine, vitamins and cardiovascular disease. Circulation 98, 196-199
16. Lindgren, A., Lindoff, C., Norrving, B., Astedt, B. and Johansson, B. B. (1996) Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients. Stroke 27, 1066-1071
17. Homocysteine Lowering Trialists' Collaboration. (1998) Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. Br. Med. J. 316, 894-898
18. Woo, K. S., Chook, P., Lolin, Y. I., Sanderson, J. E., Metreweli, C. and Celermajer, D. S. (1999) Folic acid improves arterial endothelial function in adults with hyperhomocystinemia. J. Am. Coll. Cardiol. 34, 2002-2006
19. Woo, K. S., Chook, P., Chan, L. L. et al. (2002) Long-term improvement in homocysteine levels and arterial endothelial function after 1-year folic acid supplementation. Am. J. Med. 112, 535-539
20. Verhaar, M. C., Wever, R. M., Kastelein, J. J. et al. (1999) Effects of oral folic acid supplementation on endothelial function in familial hypercholesterolemia. A randomised placebo-controlled trial. Circulation 100, 335-338
21. Chambers, J. C., Ueland, P. M., Obeid, O. A., Wrigley, J., Refsum, H. and Kooner, J. S. (2000) Improved vascular endothelial function after oral B vitamins: an effect mediated through reduced concentrations of free plasma homocysteine. Circulation 102, 2479-2483
22. Doshi, S. N., McDowell, I. F., Moat, S. J. et al. (2002) Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent or homocysteine lowering. Circulation 105, 22-26
23. Thambyrajah, J., Landray, M. J., Jones, H. J., McGlynn, F. J., Wheeler, D. C. and Townend, J. N. (2001) A randomized double-blind placebo-controlled trial of the effect of homocysteine-lowering therapy with folic acid on endothelial function in patients with coronary artery disease. J. Am. Coll. Cardiol. 37, 1858-1863
24. Title, L. M., Cummings, P. M., Giddens, K., Genest, Jr, J. J. and Nassar, B. A. (2000) Effect of folic acid and antioxidant vitamins on endothelial dysfunction in patients with coronary artery disease. J. Am. Coll. Cardiol. 36, 758-765
25. van Dijk, R. A., Rauwerda, J. A., Steyn, M., Twisk, J. W. and Stehouwer, C. D. (2001) Long-term homocysteine-lowering treatment with folic acid plus pyridoxine is associated with decreased blood pressure but not with improved brachial artery endothelium-dependent vasodilation or carotid artery stiffness: a 2-year, randomized, placebo-controlled trial. Arterioscler., Thromb., Vasc. Biol. 21, 2072-2079
26. Egerton, W., Silberberg, J., Crooks, R., Ray, C., Xie, L. and Dudman, N. (1996) Serial measures of plasma homocyst(e)ine after acute myocardial infarction. Am. J. Cardiol. 77, 759-761
27. Newby, D. E., Wright, R. A., Ludlam, C. A., Fox, K. A., Boon, N. A. and Webb, D. J. (1997) An in vivo model for the assessment of the acute fibrinolytic capacity of the endothelium. Thromb. Haemostasis 78, 1242-1248
28. Newby, D. E., Wright, R. A., Labinjoh, C. et al. (1999) Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: a mechanism for arterial thrombosis and myocardial infarction. Circulation 99, 1411-1415
29. Newby, D. E., Flint, L. L., Fox, K. A., Boon, N. A. and Webb, D. J. (1998) Reduced responsiveness to endothelin-1 in peripheral resistance vessels of patients with syndrome X. J. Am. Coll. Cardiol. 31, 1585-1590
30. Stein, C. M., Brown, N., Vaughan, D. E., Lang, C. C. and Wood, A. J. (1998) Regulation of local tissue-type plasminogen activator release by endothelium-dependent and endothelium-independent agonists in human vasculature. J. Am. Coll. Cardiol. 32, 117-122
31. Bellamy, M. F., McDowell, I. F., Ramsey, M. W. et al. (1998) Hyperhomocysteinemia after an oral methionine load acutely impairs endothelial function in healthy adults. Circulation 98, 1848-1852
32. Anderson, J. L., Muhlestein, J. B., Horne, B. D. et al. (2000) Plasma homocysteine predicts mortality independently of traditional risk factors and C-reactive protein in patients with angiographically defined coronary artery disease. Circulation 102, 1227-1232
33. Hajjar, K. A. (1993) Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor. J. Clin. Invest. 91, 2873-2879
34. Malinow, M. R., Duell, P. B., Hess, D. L. et al. (1998) Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease. N. Engl. J. Med. 338, 1009-1015
35. Bostom, A. G., Jacques, P. F., Liaugaudas, G., Rogers, G., Rosenberg, I. H. and Selhub, J. (2002) Total homocysteine lowering treatment among coronary artery disease patients in the era of folic acid-fortified cereal grain flour. Arterioscler., Thromb., Vasc. Biol. 22, 488-491
36. Thambyrajah, J., Landray, M. J., McGlynn, F. J., Jones, H. J., Wheeler, D. C. and Townend, J. N. (2000) Does folic acid decrease plasma homocysteine and improve endothelial function in patients with predialysis renal failure? Circulation 102, 871-875
37. Chowienczyk, P. J., Watts, G. F., Cockcroft, J. R. and Ritter, J. M. (1992) Impaired endothelium dependent vasodilation of forearm resistance vessels in hypercholesterolaemia. Lancet 340, 1430-1432
38. Panza, J. A., Quyyumi, A. A., Brush, Jr, J. E. and Epstein, S. E. (1990) Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N. Engl. J. Med. 323, 22-27
39. Newby, D. E., McLeod, A. L., Uren, N. G. et al. (2001) Impaired coronary tissue plasminogen activator release is associated with coronary atherosclerosis and cigarette smoking: direct link between endothelial dysfunction and atherothrombosis. Circulation 103, 1936-1941
40. Schnyder, G., Roffi, M. and Flammer, Y. et al. (2001) Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. N. Engl. J. Med. 345, 1593-1600
41. 6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial. JAMA, J. Am. Med. Assoc. 288, 973-979
42. Lange, H., Suryapranata, H., De Luca, G. et al. (2004) Folate therapy and in-stent restenosis after coronary stenting. N. Engl. J. Med. 350, 2673-2681